Use the Back button in your browser to see the other results of your search or to select another record.

Detailed Search Results

Impact of an exercise program combined with dietary advice on avoiding insulin prescription in women with gestational diabetes: a randomized controlled trial
Boulvain M, Othenin-Girard V, Jornayvaz FR, Kayser B
Diabetology & Metabolic Syndrome 2024 Sep 30;16(238):Epub
clinical trial
This trial has not yet been rated.

OBJECTIVE: To assess the effectiveness of an exercise intervention, in addition to standard care, in preventing or delaying insulin prescription in women with gestational diabetes mellitus (GDM). DESIGN: Randomised controlled trial. SETTING: University hospital. POPULATION: Pregnant women at 25 to 35 weeks of gestation diagnosed with GDM. METHODS: Women in the intervention group participated in weekly, supervised, 30 to 45 min exercise sessions and were encouraged to accumulate more than 5000 steps per day, tracked by a pedometer, in addition to receiving usual care. The control group received standard care only. MAIN OUTCOME MEASURE: Insulin prescription. RESULTS: From February 2008 through April 2013, 109 women were randomized into the intervention group (n = 57) or the usual care group (n = 52). Two women in the intervention group were excluded from the analysis (one was randomised in error and one was lost to follow-up). Six women never attended the exercise sessions, and two attended fewer than two sessions. However, two-third of women were considered as compliant to the intervention (attended more than 50% of sessions and/or averaged more than 5000 steps/day). The incidence of insulin prescription did not differ between the groups: 31 women (56%) in the intervention group versus 24 women (46%) in the control group (RR 1.22, 95% CI 0.84 to 1.78). The median time from randomization to insulin prescription was also similar between groups (14 days in the intervention group and 13 days in the control group). CONCLUSION: This study did not demonstrate that an exercise program reduces or delays insulin prescription in women with GDM. Low adherence to the intervention, a small sample size, and the short duration of the program may explain the lack of observed benefit. REGISTERED: At clinicaltrials.gov, NCT03174340, 02/06/2017.

Full text (sometimes free) may be available at these link(s):      help